	Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study. Neurotherapeutics Barbuti E, Castiello A, Pozzilli V, Carotenuto A, Tomasso I, Moccia M, Ruggieri S, Borriello G, Lanzillo R, Morra VB, Pozzilli C, Petracca M. PMID: 39880749 [PubMed - as supplied by publisher]
	Effect of vestibular rehabilitation on kinetic and kinematic parameters of gait in patients with multiple sclerosis: A single-blind randomized controlled study. Mult Scler Relat Disord Uzuno, Yeldan , Gozubatik-Celik RG, Kuchimov SN, Tütüncü M. PMID: 39879942 [PubMed - as supplied by publisher]
	Analysis of serum natalizumab concentrations obtained during routine clinical care in patients with multiple sclerosis: A cross-sectional study. Mult Scler Relat Disord Moskorova D, Kacirova I, Hradilek P, Matlak P, Brozmanova H, Kusnierova P, Licha K, Sistik P, Koristkova B, Grundmann M. PMID: 39879941 [PubMed - as supplied by publisher]
	A real-world data of serum neurofilament light chain in a large cohort of Egyptian multiple sclerosis patients: Hospital-based study. Mult Scler Relat Disord Khedr EM, Nasreldein A, El-Deen HB, El-Mokhtar MA, Mahmoud DM. PMID: 39879939 [PubMed - as supplied by publisher]
	Contribution of Blood Biomarkers to Multiple Sclerosis Diagnosis. Neurol Neuroimmunol Neuroinflamm Comabella M, Pappolla A, Monreal E, Fissolo N, Sao-Avilés AC, Arrambide G, Carbonell-Mirabent P, Gutierrez L, Cobo-Calvo Á, Tur C, Villacieros-Álvarez J, Vidal-Jordana Á, Castilló J, Galán I, Espiño M, Ariño H, Bollo L, Rodríguez Barranco M, Midaglia LS, Carvajal R, Villarrubia N, Fernández Velasco JI, Rodríguez Acevedo B, Costa Frossard LF, Vilaseca A, Auger C, Zabalza A, Sainz De La Maza S, Mongay-Ochoa N, Río J, Sastre-Garriga J, Rovira À, Tintoré M, Villar LM, Montalban X. PMID: 39879564 [PubMed - indexed for MEDLINE]
	The relationship between optical coherence tomography and magnetic resonance imaging measurements in people with multiple sclerosis: A systematic review and meta-analysis. J Neurol Sci Mirmosayyeb O, Yazdan Panah M, Moases Ghaffary E, Vaheb S, Mahmoudi F, Shaygannejad V, Lincoff N, Jakimovski D, Zivadinov R, Weinstock-Guttman B. PMID: 39874745 [PubMed - as supplied by publisher]
	A multi-country cohort database study to assess pregnancy and infant outcomes after potential maternal or paternal exposure to cladribine tablets in the treatment of multiple sclerosis: the CLEAR study methods and status update. Ther Adv Neurol Disord Hellwig K, Magyari M, MacDonald TM, Cesta CE, Wergeland S, Leinonen MK, Ornoy A, Vukusic S, Lauer A, Zhou X, Kawai A, Weinrib R, Arana A, Boumenna T. PMID: 39872126 [PubMed]
	Positive impact of cladribine tablets on reducing brain atrophy in patients with relapsing-remitting multiple sclerosis: A longitudinal study. Mult Scler Achiron A, Warszawer Y, Nissan Y, Kerpel A, Hoffmann C, Harari G, Magalashvili D, Tal S. PMID: 39871589 [PubMed - as supplied by publisher]
	Multiple Sclerosis Nursing to Improve Care and Education (MSNICE): an observational study. BMC Nurs Van Hijfte L, Cambron M, Crols R, De La Meilleure G, Govers N, Vanopdenbosch L, Laureys G, Willekens B, MSNICE Study Group. PMID: 39871334 [PubMed]
	Correlations between postmortem quantitative MRI parameters and demyelination, axonal loss and gliosis in multiple sclerosis: A systematic review and meta-analysis. Brain Imaging Behav Shen T, Sheriff S, Qu Y, Gupta VK, Graham SL, Klistorner A, Jia H, Sun X, You Y. PMID: 39871045 [PubMed - as supplied by publisher]
	Inflammatory proteins related to depression in multiple sclerosis: A systematic review and meta-analysis. Brain Behav Immun Health Kiropoulos LA, Rozenblat V, Baes N. PMID: 39867847 [PubMed]
	The current state of knowledge on the role of NKG2D ligands in multiple sclerosis and other autoimmune diseases. Front Mol Neurosci Pogoda-Weso, S, Synowiec A, Brodaczewska K, Mejer-Zahorowski M, Zi, Szypowski W, Szyma, St. PMID: 39866909 [PubMed]
	Neurotherapeutic impact of vanillic acid and ibudilast on the cuprizone model of multiple sclerosis. Front Mol Neurosci Alderbi RM, Alam MZ, Alghamdi BS, Alsufiani HM, Abd El-Aziz GS, Omar UM, Al-Ghamdi MA. PMID: 39866908 [PubMed]
	Vaccination coverage and its determinants in patients with multiple sclerosis-a multicenter cross-sectional study. Ther Adv Neurol Disord Schade P, Nguyen HA, Steinle J, Hellwig K, Pelea T, Franken P, Elias-Hamp B, Becker V, Merkelbach S, Richter S, Wagner B, Geis C, Schwab M, Rakers F. PMID: 39866752 [PubMed]
	Targeting extracellular matrix components to attenuate microglia neuroinflammation: A study of fibulin-2 and CSPGs in a model of multiple sclerosis. J Neuroimmunol Randhawa G, Mobarakabadi M, D'Mello C, Morch MT, Zhang P, Ling CC, Yong VW, Ghorbani S. PMID: 39864280 [PubMed - as supplied by publisher]
	Short and mid-term research priorities for Veterans with multiple sclerosis: A modified Delphi process engaging Veterans, researchers, and operational partners. Mult Scler Relat Disord Wooliscroft L, Turner A, Bagnato F, Knowles L. PMID: 39862462 [PubMed - as supplied by publisher]
	Ferroptosis: A New Pathway in the Interaction between Gut Microbiota and Multiple Sclerosis. Front Biosci (Landmark Ed) Jian J, Wei J. PMID: 39862079 [PubMed - indexed for MEDLINE]
	Exploring the Pathophysiology, Diagnosis, and Treatment Options of Multiple Sclerosis. J Integr Neurosci Lorenzut S, Negro ID, Pauletto G, Verriello L, Spadea L, Salati C, Musa M, Gagliano C, Zeppieri M. PMID: 39862004 [PubMed - indexed for MEDLINE]
	Clinical Insights and Radiological Features on Multiple Sclerosis Comorbid with Migraine. J Clin Med Sparaco M, Bonavita S. PMID: 39860566 [PubMed]
	Effectiveness of Ocrelizumab on Disease Progression and Disability Status in Multiple Sclerosis Patients: A Two-Year Prospective Cohort Study. J Clin Med Schuldesz AC, Tudor R, Cornea A, Geni DN, Lata IN, Simu M. PMID: 39860559 [PubMed]

Articles 1 - 20 / 40695

Page 1 of 2035



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy